Fetal adverse drug reactions with biologic Disease Modifying Anti-Rheumatic Drugs used during pregnancy: Insights from a World Health Organization pharmacovigilance database study (VigiBase (R)) - Université de Picardie Jules Verne Accéder directement au contenu
Article Dans Une Revue American Journal of Obstetrics & Gynecology MFM Année : 2022

Fetal adverse drug reactions with biologic Disease Modifying Anti-Rheumatic Drugs used during pregnancy: Insights from a World Health Organization pharmacovigilance database study (VigiBase (R))

Domaines

Médecine humaine et pathologie

Louise DESSAIVRE  : Connectez-vous pour contacter le contributeur

https://u-picardie.hal.science/hal-03712137

Soumis le : samedi 2 juillet 2022-12:36:16

Dernière modification le : mercredi 22 mars 2023-11:44:12

Fichier non déposé

Dates et versions

hal-03712137 , version 1 (02-07-2022)

Identifiants

  • HAL Id : hal-03712137 , version 1

Citer

A. Dernoncourt, S. Liabeuf, Youcef Bennis, K. Masmoudi, V. Gras-Champel, et al.. Fetal adverse drug reactions with biologic Disease Modifying Anti-Rheumatic Drugs used during pregnancy: Insights from a World Health Organization pharmacovigilance database study (VigiBase (R)). American Journal of Obstetrics & Gynecology MFM, 2022, 36 (1, SI), pp.32. ⟨hal-03712137⟩

Exporter

BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite

Collections

UVSQ UNIV-PARIS-SACLAY U-PICARDIE MP3CV
39 Consultations
0 Téléchargements

Partager

Gmail Facebook X LinkedIn More